The president indicated that duties on chips would be “approximately 100%” earlier this month.

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.

The update covers devices used in procedures to implant the company’s Watchman heart device.

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

Cardiosense has appointed John Martin as chief medical officer. The appointment puts Martin in charge of clinical development and product strategy as the company prepares for commercial launch.